Samsara BioCapital
Samsara BioCapital is a Palo Alto, California life sciences venture capital firm investing in biotech and therapeutics companies. Founded by scientists, physicians, drug developers, and business leaders with over 500 years combined experience, the firm backs entrepreneurs developing transformative therapeutics for patients.
Palo Alto, United States · 60+ investments · 93 portfolio companies
- Headquarters
- Palo Alto, United States
- Founded
- 2016
- Website
- samsaracap.com
- AUM
- $410.0M
- Portfolio Companies
- 93
- Total Investments
- 60
- Last Investment
- Aug 2026
- Geographic Focus
- Europe, United States
Indexed holds 93 portfolio companies and 60 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Samsara BioCapital is a Venture Capital firm based in Palo Alto, United States. It has made 60 investments, including DELFI Diagnostics, Genalyte and Abcuro. Focus areas include Biotech and Life Sciences.
Portfolio93
Showing 48 of 93 recorded portfolio companies.
Co-investors24
Sign up to view co-investors
24 co-investors across 162 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×18 · Hedge Fund ×4 · Corporate VC ×1 · 96 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/samsara-biocapital"><img src="https://indexed.vc/api/badge/investor/samsara-biocapital" alt="Samsara BioCapital on Indexed.vc" width="260" height="76" /></a>